Cowen and Company’s Zura Bio Limited Warrants ZURAW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-25,000
Closed -$6.49K 648
2023
Q1
$6.49K Sell
25,000
-73,066
-75% -$20.9K ﹤0.01% 434
2022
Q4
$14.7K Buy
98,066
+100
+0.1% +$10 ﹤0.01% 367
2022
Q3
$16K Buy
97,966
+77,266
+373% +$14.3K ﹤0.01% 376
2022
Q2
$4K Buy
+20,700
New +$5.61K ﹤0.01% 581

Other funds holding ZURAW

Cowen and Company's ZURAW Position: Q2 2023 in Review

Cowen and Company sold out of Zura Bio Limited Warrants (ZURAW) in Q2 2023, closing a stake of 25,000 shares — an estimated $6.49K sold.

Cowen and Company first reported a position in ZURAW in Q2 2022 and held it in 4 quarters. The position peaked at $16K in Q3 2022. 13 funds tracked by Wall St. Rank hold ZURAW as of Q2 2023.

  • Cowen and Company reported no remaining Zura Bio Limited Warrants position as of Q2 2023 after selling out during the quarter.
  • Cowen and Company sold 25,000 Zura Bio Limited Warrants shares in Q2 2023, an estimated $6.49K.
  • Cowen and Company first reported a position in Zura Bio Limited Warrants in Q2 2022 and held it in 4 quarters.
  • Cowen and Company's Zura Bio Limited Warrants position peaked at $16K in Q3 2022.
  • 13 funds tracked by Wall St. Rank held Zura Bio Limited Warrants as of Q2 2023.

Based on Cowen and Company's 13F filing for Q2 2023, filed 7 Aug 2023.